Insiders · Profile

McGrath Lynne Fahey

Director at Alzamend Neuro. Filing since 28 Mar 2022. CIK 0001866270

Company
Date
Role
Action
Shares
Amount
Of holding
23 Oct 2025
Director
Sold at will
30
$68.70
54.5%
22 Mar 2023
Director
Bought
10,000
$4.35K
opened
28 Mar 2022
Director
Bought
25,000
$30.33K
50.0%
3 decisions on file.